Vancouver, British Columbia–(Newsfile Corp. – April 29, 2021) – Lobe Sciences Ltd. (“ Lobe” or the “Company“) (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the filing of a key Patent Cooperation Treaty (“PCT”) application entitled Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic…

Source

Previous articleMINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM’s Market Launch, Delivering Mental Wealth
Next articleBexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation